BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12140374)

  • 1. Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest.
    Smalley KS; Eisen TG
    Melanoma Res; 2002 Jun; 12(3):187-92. PubMed ID: 12140374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells.
    Smalley K; Eisen T
    FEBS Lett; 2000 Jul; 476(3):198-202. PubMed ID: 10913613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
    Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
    Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells.
    Finn GJ; Creaven BS; Egan DA
    Eur J Pharm Sci; 2005 Sep; 26(1):16-25. PubMed ID: 15996858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase.
    Lee SA; Son YO; Kook SH; Choi KC; Lee JC
    Arch Dermatol Res; 2011 Nov; 303(9):669-78. PubMed ID: 21667118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p38 MAPK in lupeol-induced B16 2F2 mouse melanoma cell differentiation.
    Hata K; Hori K; Takahashi S
    J Biochem; 2003 Sep; 134(3):441-5. PubMed ID: 14561730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi YH; Kim BW; Shin HK; Choi BT
    J Ethnopharmacol; 2012 May; 141(1):338-44. PubMed ID: 22414478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tokoronin Contained in Dioscorea tokoro Makino ex Miyabe Suppressed α-MSH-Induced Melanogenesis in B16 Cells via Suppression of Classical MAPK Pathway Activation.
    Ukiya M; Sato D; Kimura H; Hirai Y; Nishina A
    Chem Biodivers; 2020 Jun; 17(6):e2000077. PubMed ID: 32378303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells.
    Kintscher U; Bruemmer D; Blaschke F; Unger T; Law RE
    Biochem Biophys Res Commun; 2003 Jun; 305(3):552-6. PubMed ID: 12763029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
    Hayes SA; Huang X; Kambhampati S; Platanias LC; Bergan RC
    Oncogene; 2003 Jul; 22(31):4841-50. PubMed ID: 12894225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects.
    Smalley KS; Eisen TG
    Int J Cancer; 2002 Apr; 98(4):514-22. PubMed ID: 11920610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells.
    Wang X; Rao J; Studzinski GP
    Exp Cell Res; 2000 Aug; 258(2):425-37. PubMed ID: 10896794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
    Hu X; Janssen WE; Moscinski LC; Bryington M; Dangsupa A; Rezai-Zadeh N; Babbin BA; Zuckerman KS
    Cancer Res; 2001 Aug; 61(16):6290-6. PubMed ID: 11507084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
    Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity.
    Reiling N; Blumenthal A; Flad HD; Ernst M; Ehlers S
    J Immunol; 2001 Sep; 167(6):3339-45. PubMed ID: 11544323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.